Wiley Bros. Aintree Capital, LLC HALOZYME THERAPEUTICS INC Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
Number of Shares
143,000
Previous 81,000
76.54%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%